our team
leadership
Laura Benjamin, PhD
FOUNDER & CEO

Laura brings scientific vision and leadership experience from her years as faculty at Harvard Medical School and Vice President at ImClone Systems and Eli Lilly. She has focused her scientific career on cancer biology and clinical biomarker strategies.

David Malek, MBA
Chief Business Officer

David brings experience in business development as well as executive managerial experience in public companies, Sanofi and BiolineRx.

Jessicca Rege, PhD
Chief Development Officer

Jessicca is an oncology leader with many years of experience in both clinical development and medical affairs supporting the development and approval of oncology products, such as Cyramza® , Halaven®, Lenvima®, and Sprycel®.

Hagop Youssoufian, MD
Acting Chief Medical Officer

Hagop is an experienced oncology drug developer with tenures in several pharmaceutical and biotech companies, including as Chief Medical Officer at ImClone-Lilly and as President of R&D at Ziopharm. He was involved in the development and approval of multiple oncology biologics, such as Erbitux®, Cyramza®, and Taxotere®.

team
Our Boston Team
Our Shanghai Team
Shanghai_Team-web
our team
leadership

Laura Benjamin, PhD

Chief Executive Officer

David Malek, MBA

Chief Business Officer

Jessicca Rege, PhD

Chief Development Officer

Hagop Youssoufian, MD

Acting Chief Medical Officer

team
Our Boston Team
Our Shanghai Team
Shanghai_Team-web

 

This website uses cookies. By continuing to use this website you are giving consent to cookies being used.